Glyscend Incorporated


Founded in 2014, Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes.

Industries

Employees

11-50

Links


Org chart

Collapse
Ashish Nimgaonkar
Chief Medical Officer & Head, R&D

Board & advisors

Jiten Vora
Chief Medical Advisor
Bob Soh
Director
Louis Bock
Director
Jay Pasricha
Founder & Advisor
Andrew Young
Scientific & Clinical Advisor
Ralph Defronzo
Scientific & Clinical Advisor
Alain Baron
Scientific & Clinical Advisor


Offices